CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 8-K Event Material agreement
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,035 shares at $46.17 ($93,956)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 4,069 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $41.03 ($83,455)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $48.01 ($97,652)
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $46.99 ($422,874)
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Chief Commercial Officer sold 7,576 shares at an average $49.23 ($372,937)
- 144 Insider Sale of Securities
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
Page 1 of 97 · 1,927 filings